Invetx

Provider of pharmaceutical products like protein-based therapeutics for pets

placeBoston, Massachusetts, United States calendar_todayFounded 2018 groups11 employees language invetx.com

Innovation

14 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace accelerating. Cited 1,263 times.

YearFilings
20201
20212
20223
20235
20248
202512
20262

Investor mix

9 investors on record; lead investors include Anterra Capital, Casdin Capital, F-Prime Capital, Novo Holdings; 3 have since exited.

Investor typeCountShare
Venture capital556%
Other / undisclosed444%
Coming soon